End of injection indicator for injection pen

ABSTRACT

A medication injection pen ( 50 ) includes a housing ( 1 ) and a dose set knob ( 2 ) rotatably connected to the housing ( 1 ) for setting a dose. An indicator member ( 200 ) is movable between a visible position indicating a zero position of the dose set knob ( 2 ) and a non-visible position indicating a non-zero position of the dose set knob ( 2 ). The indicator member is visible to a user in the visible position and not visible to the user in the non-visible position. The dose set knob is in the zero position when a set dose has been completely administered. Accordingly, a visible indication is provided to the user when a set dose has been completely administered.

FIELD OF THE INVENTION

This application is a continuation of U.S. patent application Ser. No.14/005,603, filed on Sep. 17, 2013, which is a U.S. national stageapplication under 35 U.S.C. §371 of International Application No.PCT/US12/029545, filed on Mar. 16, 2012, which claims the benefit under35 U.S.C. §119(e) of U.S. Provisional Patent Application Ser. No.61/457,403, filed on Mar. 18, 2011, the entire content, disclosure andsubject matter of all of these applications being expressly incorporatedherein by reference.

FIELD OF THE INVENTION

The invention relates to a multiple use pen-type injection device withan end of injection indicator to signal to a user that a set dose wascompletely injected.

BACKGROUND OF THE INVENTION

Various medication injection pen devices are known in the prior art.Many injection pen devices require a user to set a desired dosewhereupon a dose dial, a driver, or some other element moves a distanceout of a main pen body corresponding to the set dose. To inject the dosein such injection pens, the user then pushes a button or some otherfeature which generally returns the dose dial or driver to its initialposition in the main pen body while injecting the set dose. In many suchpens, the user must continue pressing the push button until the set doseis completed. However, one problem with many of these pens is that thereis no indication to the user that the set dose was completelyadministered. Thus, the user may prematurely release the push buttonthinking the injection process is complete without being informedotherwise. In some situations, this could pose a risk for the userbecause the prescribed dose was not fully injected. Accordingly, thereis a need to provide one or more of a visible, tactile and audibleindication to a user when the set dose has been completely administered.

SUMMARY OF THE INVENTION

Exemplary embodiments of the present invention address at least theabove problems and/or disadvantages and provide at least the advantagesdescribed below.

In accordance with an exemplary embodiment of the present invention, amedication injection pen includes a housing and a dose set memberconnected to the housing for setting a dose. An indicator member ismovable between a visible position indicating a zero position of thedose set member and a non-visible position indicating a non-zeroposition of the dose set member. The indicator member is visible to auser in the visible position and not visible in the non-visibleposition. The dose set member is in the zero position when a set dosehas been completely administered. Accordingly, a visible indication isprovided to a user when a set dose has been completely administered.

In accordance with another exemplary embodiment of the presentinvention, a medication injection pen includes a housing and a dose setmember rotatably connected to the housing for setting a dose. A windowis disposed in the housing such that a portion of the outer surface ofthe dose set member is visible in the window to indicate a zero positionof the dose set member and the portion of the outer surface of the doseset member is not visible in the window to indicate the non-zeroposition. The dose set member is in the zero position when a set dosehas been completely administered.

Additional objects, advantages and salient features of exemplaryembodiments of the present invention will become apparent to thoseskilled in the art from the following detailed description, which, takenin conjunction with the annexed drawings, discloses exemplaryembodiments of the present invention.

BRIEF DESCRIPTION OF THE DRAWINGS

The above and other exemplary features and advantages of certainexemplary embodiments of the present invention will become more apparentfrom the following description of certain exemplary embodiments thereofwhen taken in conjunction with the accompanying drawings in which:

FIG. 1 is an elevational view of an injection pen according to anexemplary embodiment of the present invention;

FIG. 2 is a perspective view of an end of injection indicator when theindicator is visible according to a first exemplary embodiment of thepresent invention;

FIG. 3 is a perspective view of the end of injection indicator of FIG. 2when the indicator is not visible;

FIG. 4 is a perspective view of an end of injection indicator when theindicator is visible according to a second exemplary embodiment of thepresent invention;

FIG. 5 is a perspective view of the end of injection of FIG. 3 when theindicator is not visible;

FIG. 6 is a perspective view of a dose set knob in the embodiments ofFIGS. 2-5;

FIG. 7 is a perspective view of an end of injection indicator when anindicator member is visible according to a third exemplary embodiment ofthe present invention;

FIG. 8 is a perspective view of the end of injection indicator of FIG. 7when the indicator member is not visible;

FIG. 9 is an elevational view in cross-section of the end of injectionindicator of FIGS. 7 and 8;

FIG. 10 is a perspective view of the end of injection indicator of FIG.7 with the indicator member in a visible position;

FIG. 11 is a perspective view of the end of injection indicator of FIG.7 in which a lug of a dose set knob engages the indicator member toretract the indicator member;

FIG. 12 is a perspective view of the end of injection indicator of FIG.11 in which the indicator member is fully retracted and disengaged fromthe lug in the non-visible position;

FIG. 13 is a perspective view of the end of injection indicator of FIG.12 in which the indicator member is engaged by a thread of the dose setknob to release the indicator member to the visible position;

FIG. 14 is a perspective view of an end of injection indicator inaccordance with a fourth exemplary embodiment of the present inventionin which an indicator member is in a visible position;

FIG. 15 is a perspective view of the end of injection indicator of FIG.14 in which a lug of a dose set knob engages a driver to move theindicator member to a non-visible position;

FIG. 16 is a perspective view of the lug of the dose set knob disengagedfrom the driver;

FIG. 17 is a perspective view of a thread of the dose set knob engagingthe driver to move the indicator member to the visible position;

FIG. 18 is a perspective view of an end of injection indicator accordingto a fifth exemplary embodiment of the present invention in which anindicator member is in a visible position;

FIG. 19 is a perspective view of the end of injection indicator of FIG.18 with the indicator member in a non-visible position;

FIG. 20 is a perspective view of an injection pen having an end ofinjection indicator in accordance with a sixth exemplary embodiment ofthe present invention with the indicator member shown in the visibleposition;

FIG. 21 is a perspective view of the injection pen of FIG. 20 with theindicator member shown in a non-visible position;

FIG. 22 is a perspective view of the indicator member of FIG. 20 in thevisible position;

FIG. 23 is a perspective view of the indicator member of FIG. 20 in thenon-visible position;

FIG. 24 is a perspective view of an injection indicator according to aseventh exemplary embodiment of the present invention with the indicatorshown in a visible position;

FIG. 25 is another perspective view of the injection indicator of FIG.24 with the indicator member shown in the visible position;

FIG. 26 is a perspective view of the injection indicator of FIG. 24 withthe indicator member shown in the non-visible position;

FIG. 27 is another perspective view of the injection indicator of FIG.24 with the indicator member shown in the non-visible position;

FIG. 28 is a perspective view of the injection indicator of FIG. 24 withthe indicator member moving from the non-visible position to the visibleposition;

FIG. 29 is a perspective view of the injection indicator of FIG. 24 withthe indicator member being engaged by a dose set know thread;

FIG. 30 is a partial elevational view in cross-section of an injectionpen including the injection indicator of FIG. 24 in the non-visibleposition; and

FIG. 31 is a partial elevational view in cross-section of the injectionpen of FIG. 30 with the indicator member in the visible position.

Throughout the drawings, like reference numerals will be understood torefer to like elements, features and structures.

DETAILED DESCRIPTION OF EXEMPLARY EMBODIMENTS

The matters exemplified in this description are provided to assist in acomprehensive understanding of exemplary embodiments of the inventionwith reference to the accompanying drawing figures. Accordingly, thoseof ordinary skill in the art will recognize that various changes andmodifications of the exemplary embodiments described herein can be madewithout departing from the scope and spirit of the disclosedembodiments. Also, descriptions of well-known functions andconstructions are omitted for clarity and conciseness.

FIG. 1 depicts a view of an injection pen 50 according to an exemplaryembodiment of the present invention. As shown, the injection pen 50includes an upper pen body 1, which houses a plurality of dose settingand injection components. The upper body 1 is connected to a cartridgehousing 15, which houses a medication cartridge 14. The cartridgehousing 15 is preferably transparent or translucent. As shown, theinjection pen includes a dose set knob 2 that includes a knob-likeportion 51 that is rotated by a user to set a desired dose. The dose setknob 2 also includes a plurality of numerals corresponding to a numberof dosage units that is visible through a window 13 provided on theupper body 1. A user rotates the dose set knob 2 until the desired doseis visible in the window 13. The body 1 may include an arrow or otherindicator 52 to precisely indicate the set dose. Once the desired doseis set, a user presses the button 3 until the set dosage amount iscompletely injected.

To set a dose using the injection pen device 50, the user rotates theknob-like portion 51 of the dose set knob 2 relative to the pen upperbody 1. The outer surface 53 of the dose set knob 2 includes a thread21, as shown in FIG. 6, that is in threaded engagement with a pluralityof threads (not shown) provided on an inner surface of the pen body 1.Accordingly, as the dose set knob 2 is rotated relative to the pen body1, the dose set knob 2 screws or advances a distance out of the pen body1, as shown in FIG. 21. Once a desired dose is set, the user pushes thepush button 3 to initiate injection. As the user continues to press thebutton 3, the dose set knob 2 is caused to rotate and screw back downinto the body via the thread engagement between external thread 21 onthe dose set knob 2 and the internal threads in the upper body 1.Rotation of the dose set knob 2 may then be transferred to a driver orother element that causes a piston rod or lead screw 6 to move intocartridge 14 to inject the set dose, as shown in FIG. 2. A more detaileddescription of the operation of an exemplary injection pen device can befound in U.S. Provisional Patent Application No. 61/457,391, filed onMar. 16, 2011, and in related International Patent Application No.PCT/US2012/029308, filed on Mar. 15, 2012, both applications entitled“Multiple Use Disposable Injection Pen”, and are hereby incorporated byreference in their entirety.

The injection process is completed when the dose set knob 2 returns toits initial or ‘0’ dose position inside pen body 1, such that it isblocked from further rotation and or axial movement in the injectiondirection, i.e., toward a distal end 54 of the injection pen 50 as shownin FIG. 1. According to the first exemplary embodiment shown in FIG. 2,the pen upper body 1 may include one or more windows 17, through which aportion of the dose set knob 2 is visible only when the dose set knob 2is at a ‘0’ dose position, such as at the end of injection, when thedose set knob 2 returns to its initial position. The window 17 isdisposed in the pen upper body 1 adjacent a distal end 55 of the penupper body 1. Accordingly, a user can be assured that the injectionprocess is complete only when a portion of the dose set knob is visiblethrough the window 17. Preferably, an elongated side 18 of the window 17is substantially perpendicular to a longitudinal axis of the pen upperbody 1.

When the dose set knob 2 is in the initial position, a distal end 56(FIG. 6) of the dose set knob 2 is substantially adjacent the distal end55 of the pen upper body 1 such that a portion of the dose set knob 2 isvisible through the window 17 in the pen upper body 1. When a dose isbeing set, the dose set knob 2 is advance in a distal direction out ofthe upper pen body, as shown in FIG. 21, such that the distal end 56 ofthe dose set knob 2 is advanced proximally of the window 17 in the penupper body 1. Thus, the dose set knob 2 is not visible through thewindow 17, as shown in FIG. 3. As shown, the dose set knob 2 is not at a‘0’ dose position, thus either a dose is set, or the injection processis not completed. When the dose is completed, the dose set knob 2 isagain visible through the window 17 in the pen upper body 1 because thedistal end 56 of the dose set knob 2 is returned to its initial positionsubstantially adjacent the distal end 55 of the pen upper body 1.

An end of injection indicator in accordance with a second exemplaryembodiment is shown in FIGS. 4 and 5, which illustrate an injection pensubstantially similar to that of FIGS. 2 and 3. A window 19 is disposedin the upper pen body 1, as shown in FIGS. 4 and 5. The window 19 has adifferent orientation than that of the window 17 of FIGS. 2 and 3. Thewindow 19 has an elongated dimension 20 that is substantially parallelto a longitudinal axis of the pen upper body 1, as opposed to theelongated dimension 18 of the window 17 being substantiallyperpendicular to the longitudinal axis of the pen upper body 1 as shownin FIGS. 2 and 3.

The end of injection indicator of FIGS. 4 and 5 operates substantiallysimilarly to that of FIGS. 2 and 3. When the dose set knob 2 is notvisible through the window 19, as shown in FIG. 5, the dose set knob 2is not at an initial or ‘0’ dose position, i.e., a dose is being set orhas not been completed. When the dose set knob 2 is visible through thewindow 19, as shown in FIG. 4, the dose set knob 2 is in the initial or‘0’ dose position.

The dose set knob 2 shown in FIG. 6 can be used with the exemplaryembodiments described above with respect to FIGS. 2-5. As shown, thedose set knob 2 is of a generally cylindrical shape. To ensure that noportion of the dose set knob 2 is visible through the window 17 or 19until the dose set knob 2 is in the initial or ‘0’ dose position, thedose set knob 2 may include a cut-away portion 23. As shown in FIG. 6,the cut-away portion 23 is formed by an inverted substantially V-shapedcut made at the distal end 56 of the dose set knob 2. Because the doseset knob 2 rotates to return to the ‘0’ dose position during aninjection, the cut-away portion 23 is preferably removed from a portionof the outer surface as shown. Thus, even when the dose set knob 2 isvery close to returning to its initial or ‘0’ dose position, no portionof the dose set knob 2 is visible through the window 17 or 19 until thedose set knob 2 is fully rotated back into the pen upper body 1.Alternatively, instead of providing a cut-away portion 23 of the doseset knob 2, a printed line or block can be provided on a portion of theouter surface 53 of the dose set knob 2 that would only be visible whenthe dose set knob 2 is in the ‘0’ dose position. Additionally, while theexemplary embodiments shown in FIGS. 2-5 illustrate only a single windownear the distal end 55 of the upper pen body 1, a plurality of windowscan be utilized in various positions on the pen upper body 1.

An end of injection indicator according to a third exemplary embodimentof the present invention is shown in FIGS. 7 and 8. An indicator member200 is in the visible or exposed position and is visible only when thedose set knob 2 is in the ‘0’ dose or initial position as shown in FIG.7. Accordingly, as shown in FIG. 8, when the dose set knob 2 is not inits initial position, as evident by the gap ‘a’ between the dose setknob 2 and the pen upper body 1, the indicator member 200 is no longerin the visible position. The exposed indicator member 200 is morereadily visible to the user when the dose set knob 2 is in its initialor end of injection position due to the larger size of the indicatormember 200. The cartridge housing 15 is preferably transparent ortranslucent to facilitate visibility of the indicator member 200 in thevisible position.

The energy used to activate the indicator member 200 of FIGS. 7 and 8 isstored during the dose setting action performed by the user. Tofacilitate the injection process, the force required to release theindicator member 200 to the visible position is preferably minimal andunnoticeable to the user. A cross-section of an end of injectionmechanism to expose the indicator member 200 of FIGS. 7 and 8 is shownin FIG. 9.

Operation of the injection mechanism is shown in FIGS. 10-13, in whichthe pen body 1 and the cartridge holder 15 are removed to more clearlyillustrate the operation thereof

As shown in FIG. 10, the indicator member 200 is of a substantiallycylindrical shape and coaxially surrounds an insert 300. The insert 300is held axially and rotatably fixed with respect to a pen upper body orhousing 1, as shown in FIG. 9. FIGS. 9 and 10 depict the indicatormember 200 in the visible or exposed position, visible to a user. Assuch, the dose set knob 2 is in its initial or ‘0’ dose position. Asshown in FIG. 9, a portion of the indicator element 200, represented bya length ‘b’, is visible between the pen body 1 and the cartridgehousing 15 when the indicator member 200 is in the visible position. Thecartridge housing 15 is preferably transparent or translucent tofacilitate visibility of the indicator member 200. A compression springelement 400 is provided coaxially surrounding the insert 300 between aledge 307 of the insert member 300 and a ledge 207 of the indicatormember 200. In this position, the spring element 400 is biasing theindicator member 200 away from the dose set knob 2 to expose theindicator member 200 to the user. The indicator member 200 is connectedto the insert member 300 via engagement between a boss 302 on the insertmember 300 and a track 204 of the indicator member 200. The indicatormember 200 is rotatable with respect to the insert member 300. Therotatable movement of the indicator member 200 is determined by theconfiguration of the track 204 in the indicator member 200.

As shown in FIG. 10, the track 204 has a first or inclined portion 205extending in a distal direction at an angle to the longitudinal axis ofthe pen upper body 1. A second or horizontal portion 206 of the track204 extends substantially perpendicular to the longitudinal axis of thepen upper body 1 from an end 208 of the first portion 205 of the track204.

The indicator member 200 includes at least one arm 202 extending from acylindrical portion of the indicator member 200 towards the dose setknob 2. A cut-out portion 210 is formed in a proximal end of the arm 202to form a flexible arm 209 at the proximal end thereof. The arm 202 ofthe indicator member 200 engages a lug 25 provided adjacent the distalend 56 of the dose set knob 2, as shown in FIG. 10. During setting of adose, as the dose set knob 2 is rotated, the lug 25 on the dose set knob2 engages a portion of the arm 202 to cause the indicator member 200 torotate, as shown in FIG. 11. As the indicator member 200 rotates, theinclined track portion 205 of the indicator member 200 performs acamming function with the boss 302 on the insert 300 such that theindicator member 200 retracts into the body 1 as the boss 302 traversesthe inclined track portion 205. As the indicator member 200 retracts,the compression spring 400 compresses between the indicator member 200and the insert member 300, which is fixed and does not move axially orrotationally. When the boss 302 reaches an end 208 of the inclined trackportion 205, the indicator member 200 is fully retracted in the pen body1 and is not visible to the user, as shown in FIG. 11. The indicatormember 200 may further rotate with rotation of the dose set knob 2 untilthe boss 302 reaches an end of the horizontal track portion 206. As thedose set knob 2 continues to rotate, the lug 25 on the dose set knob 2moves away from engagement with the arm 202 of the indicator member 200.Eventually the lug 25 on the dose set knob 2 will move far enough thatit no longer engages the arm 202 of the indicator 200, as shown in FIG.12. At this point the indicator 200 no longer rotates and the dose setknob 2 rotates and screws or advances out of the pen upper body 1 adistance corresponding to a set dose, as shown in FIG. 8. The boss 302is positioned at an end 212 of the horizontal portion 206 of the track204, as shown in FIG. 12. The boss 302 being disposed in the horizontalportion 206 of the track 204 prevents movement of the indicator member200 in the distal direction such that the spring 400 (FIG. 9) remainscompressed between the indicator member 200 and the insert 300.

During an injection, the dose set knob 2 is screwed back down into thepen upper body 1 upon a user pressing on the button 3 (FIGS. 7 and 8).As the dose set knob 2 nears the end of injection position or the ‘0’dose position, the dose set knob 2 can reach a position where the lug 25on the dose set knob 2 engages the top of the arm 202 of the indicatormember 200, as shown in FIG. 12. If the lug 25 were to hit the top ofthe arm 202 instead of passing over the top, it is possible that the pencould jam and the set dose would not be allowed to be completed.Accordingly, the arm 202 on the insert member 200 can include the cutoutportion 210 near the top of the arm 202 forming the flexible arm 209.Thus, when the lug 25 contacts the top surface of arm 202, the flexiblearm 209 flexes out of the way of the lug 25 so that the dose set knob 2can continue to its initial position or ‘0’ dose position.

Once the lug 25 passes the arm 202, a thread 21 on the dose set knob 2contacts a side edge of the arm 202, thus causing rotation of theindicator member 200, as shown in FIG. 13. This interaction preferablyoccurs just before the dose set knob 2 reaches the ‘0’ dose position. Asthe indicator member 200 rotates, the horizontal track portion 206 ofthe track 204 moves over the boss 302 on the insert member 300, asshown. Once the track 204 moves such that the boss 302 is positioned inthe inclined track portion 205, the spring 400 (FIG. 9) is released. Thespring 400 drives the indicator member 200 in a distal direction awayfrom the insert 300, until the boss 302 is positioned at an end 213 ofthe inclined track portion 205 of the track 204, as shown in FIG. 10.The end 213 of the track contacting the boss 302 results in a click orsnap sound at the end of travel, thereby providing an audible indicationthat the injection is complete. The critical point when the boss 302 ispositioned in the inclined track portion 205 of the track 204 is whenthe dose set knob 2 has returned to the ‘0’ dose position, such that theinjection is completed. The axial movement of the indicator member 200as the inclined track portion 205 moves over the boss 302 moves theportion of the indicator member 200 into the visible position externalof the pen upper body 1, thereby providing the user with a visibleindication that the injection is complete.

In a fourth exemplary embodiment shown in FIGS. 14-17, a driver 500 isadded to supplement the movement of the indicator member 251. Theindicator member 251 is allowed to move an axial distance in and out ofthe body such that a portion of the indicator member 251 can be visibleor exposed to the user in a ‘0’ dose or initial position, but hiddenwhen the dose set knob 2 is not in the ‘0’ dose or initial position, asshown in FIGS. 7 and 8. The indicator member 251 does not rotate, and islimited to axial movement. An insert 271 is fixed to the pen upper body1, thereby preventing rotational and axial movement of the insert 271.The driver 500 is provided such that it rotates with respect to the penupper body 1, but does not move axially in and out of the pen upper body1.

The driver 500 includes a first horizontal track portion 510 that isengaged with a boss 272 on the insert 271 to axially fix the driver 500to the insert 271 while allowing rotation with respect thereto.Accordingly, the rotational distance over which the dose set knob 2 andan arm 502 of the driver 500 are engaged at the beginning of dosesetting and near the end of injection is reduced. Accordingly, anypotential for the injection mechanism to jam or fail due to suchengagement can be reduced or minimized.

As shown in FIG. 14, the dose set knob 2 is in the ‘0’ dose or initialposition, thus an indicator member 251 is visible or exposed to theuser. As in the third exemplary embodiment shown in FIGS. 9-13, a springmember (not shown) is provided between the insert 271 and the indicator251 and is biased to push the indicator member 251 away from the doseset knob 2. As before, when the user adjusts the dose set knob 2 to seta desired dose, the dose set knob 2 is rotated and a lug 25 on the doseset knob 2 engages an arm 502 extending axially from a driver 500. Dueto this engagement, the driver 500 is caused to rotate. The driver 500includes an inclined track portion 504 that engages with a boss 257provided on the indicator member 251. As the driver 500 rotates, theboss 257 is caused to slide into and up the inclined track portion 504of the driver 504, thus causing the indicator member 251 to move up intothe pen upper body 1 against the bias of the spring member 400 (FIG. 9).The indicator member 251 continues to retract into the pen upper body 1until the boss 257 reaches the horizontal track portion 505 of thedriver 500. At this point, as shown in FIG. 15, the indicator member 251is completely retracted and the arm 502 is no longer engaged with thelug 25 on the dose set knob 2. Since the arm 502 on the driver 500 doesnot retract into the pen body with the retraction of the indicatormember 251, as in the previous embodiment, the arm 502 and the dose setknob 2 are engaged for a shorter period of time and over a shorterrotational distance. The boss 257 being positioned in the horizontaltrack portion 505 maintains the spring member in the compressedposition.

During injection, the dose set knob 2 moves back toward its ‘0’ dose orinitial position toward arm 502 of the driver element 500. When the lug25 engages with a top edge of the arm 502 during return of the dose setknob 2, a flexible arm 509 of the driver arm 502 flexes downwardly suchthat the lug 25 can move past the arm 502 of the driver 500. The driver500 rotates upon engagement of a thread 21 on the dose set knob 2 withthe side edge of the arm 502, as shown in FIG. 16. As the driver 500rotates, the boss 257 moves in the horizontal portion of track 505, asshown in FIG. 17, until it reaches the inclined track portion 504. Atthis point, the spring element 400 (FIG. 9) disposed between the insert271 and the indicator member 251 is released and pushes the indicatormember 251 away from the dose set knob 2 and out of the pen upper body 1such that it is visible to the user. Once again, when the boss 257reaches an end 515 of the inclined track portion 504, as shown in FIG.14, an audible and/or tactile click or snap is generated.

FIGS. 18 and 19 illustrate a fifth exemplary embodiment of an end ofinjection indicator. A generally cylindrical indicator member 600surrounds an insert member 700 to provide an indication that the doseset knob 620 has returned to its ‘0’ dose or initial position similar tothe above exemplary embodiments. The indicator member 600 includes an atleast one elongate arm 602 that engages the dose set knob 620. The doseset knob 620 in this exemplary embodiment includes an angled lug 625that engages a corresponding angled portion 603 on the internal surfaceof the arm 602 to lift the indicator member 600 upon rotation of thedose set knob 620. As the dose set knob 620 is rotated to set a dose,the indicator member 600 is lifted or pulled into the pen upper body 1,against the bias of a spring member 400 (FIG. 9) disposed between theinsert 700 and the indicator member 600. The indicator member 600 ismoved axially into the upper pen body 1 a distance corresponding to thelength of a vertical track portion 604 of the indicator member. Theindictor member 600 is lifted by the engagement with the lug 625 on thedose set knob 620 just enough for a boss 702 on an insert member 700 totraverse the length of the vertical track portion 604 and move into thehorizontal portion 605, as shown in FIG. 19, that secures the indicatormember 600 in the retracted position until the dose set knob 620 returnsto the ‘0’ dose or initial position. The spring member 400 (FIG. 9)remains compressed when the boss 702 is disposed in the horizontal trackportion 605 and prevents axial movement of the indicator member 600.

FIG. 19 illustrates the indicator member 600 just before the dose setknob 620 returns to the ‘0’ dose or initial position. As shown, justbefore the dose set knob 620 reaches the ‘0’ dose or initial position, athread 621 on the dose set knob 620 engages an edge of the arm 602 tocause the arm 602 to rotate a slight amount that will release the boss702 disposed on the insert 700 from the horizontal track portion 605into the vertical track portion 604. Once the boss 702 is aligned in thevertical track portion 604, the spring member 400 (FIG. 9) releases andpushes the indicator member 600 away from the dose set knob 620, suchthat a portion of the indicator member 600 is exposed outside the penupper body 1 similar to the above exemplary embodiments to be visible tothe user. As before, when the boss 702 reaches an end 606 of thevertical track portion 604, an audible and/or tactile click or snap isgenerated.

According to a sixth exemplary embodiment shown in FIGS. 20-23, insteadof pushing an indicator out from the pen upper body 1 such that it isexposed or visible to a user, an indicator 800 is configured to rotatesuch that a portion of indicator 800 is visible to the user. As shown inFIG. 22, an indicator member 800 includes a plurality of legs 804 thatare circumferentially spaced apart. Thus, as the indicator member 800rotates relative to the pen upper body 1, one of the legs 804 rotatesinto a view of the user, as shown in FIG. 20. FIG. 22 illustrates thisembodiment when the dose set knob 2 is rotated an amount to set a dose,such that the dose set knob 2 is no longer in the ‘0’ dose or initialposition. As shown, none of the legs 804 of the indictor member 800 arevisible to the user. Instead, a portion of the cartridge holder 15 maybe visible.

One difference between the embodiment of FIGS. 20-23 and the previousembodiments is that a torsion spring is provided between an insert 900and the indicator member 800 instead of a compression spring. As shownin FIG. 22, the indicator member 800 includes a track 805 that engageswith a boss 902 provided on the insert member 900. At least one arm 802extends from the indicator member toward and engages the dose set knob820. The dose set knob 820 is provided with an angled lug 825, as shownin FIG. 23, that engages with a similar angled member 808 provided onthe internal surface of arm 802. As the dose set knob 820 is rotated toset a desired dose, engagement between the angled portions 825 and 808causes the indicator member 800 to lift or move into the pen upper body1 a small amount and rotate against the bias of the torsion spring tomove the boss 902 disposed on the insert 900 into a secured position,not shown, within the track 805. The boss 902 is held in the securedposition against the bias of the torsion spring until the arm 802 isengaged near the ‘0’ dose or initial position by the dose set knob 820.Once the dose set knob 820 engages the arm 802 during its return, theindicator member 800 is rotated an amount that releases the boss 902such that the torsion spring causes the indicator member 800 to rotateback. Once the indicator member 800 rotates back with the force of thetorsion spring, one of the legs 804 are visible to a user to indicatethat the dose set knob 820 is in the ‘0’ dose or initial position.Return of the boss 902 in the track 805 under the force of the springmember results in an audible and/or tactile click or snap perceivable tothe user.

An end of injection indicator according to a seventh exemplaryembodiment of the present invention is shown in FIGS. 24-31. Anindicator member 1021 is in the visible or exposed position and isvisible only when the dose set knob 1002 is in the ‘0’ dose or initialposition as shown in FIGS. 24 and 25. Accordingly, as shown in FIGS.26-29, when the dose set knob 1002 is not in its initial position (forexample, as shown by the gap ‘a’ between the dose set knob 2 and the penupper body 1 in FIG. 8), the indicator member 1021 is no longer in thevisible position. The exposed indicator member 1021 is more readilyvisible to the user when the dose set knob 1002 is in its initial or endof injection position due to the indicator member 200 extending beyond adistal end 1004 of a pen upper body 1003, as shown in FIG. 31. Thecartridge housing 15 (FIGS. 7 and 8, for example) is preferablytransparent or translucent to facilitate visibility of the indicatormember 1021 in the visible position.

The energy used to activate the indicator member 1021 of FIGS. 24-31 isstored during the dose setting action performed by the user. Tofacilitate the injection process, the force required to release theindicator member 1021 to the visible position is preferably minimal andunnoticeable to the user. A cross-section of an end of injectionmechanism to expose the indicator member 1021 is shown in FIGS. 30 and31. Operation of the injection mechanism is shown in FIGS. 24-29, inwhich the pen body 1003 and the cartridge holder 15 (FIGS. 7 and 8) areremoved to more clearly illustrate the operation thereof.

As shown in FIGS. 24-29, the indicator member 1021 is of a substantiallycylindrical shape and is coaxially surrounded by an insert 1031. Theinsert 1031 is prevented from moving axially in the distal direction byand outwardly extending flange 1005 of the brake tower 1005 receiving aninwardly extending shoulder 1033 of the insert 1031. Axial movement inthe proximal direction and rotational movement with respect to the penupper body 1003 is substantially prevented by a boss 1023 of theindicator member 1021 received in a track 1035 of the insert 1031. Aspring member 1041 is disposed between the flange 1005 of the braketower 1005 and a proximal end 1025 of the indicator member 1021, asshown in FIGS. 30 and 31. The spring member 1041 biases the indicatormember 1021 to the visible position shown in FIGS. 24 and 25, andprevents movement of the indicator member 1021 and the insert 1031 dueto the boss 1023 and track 1035 connection therebetween.

FIGS. 24 and 25 depict the indicator member 1021 in the visible orexposed position, such that a portion of the indicator member 1021 isvisible to the user through the transparent or translucent cartridgehousing 15 (FIGS. 7 and 8). As such, the dose set knob 1002 is in itsinitial or ‘0’ dose position. A portion of the indicator member 1031 ata distal end 1027 thereof is visible beyond the distal end 1004 of thepen upper body 1003 when the indicator member 1021 is in the visibleposition.

As shown in FIGS. 24-29, the track 1035 has a first or inclined portion1036 extending in a distal direction at an angle to the longitudinalaxis of the pen upper body 1003 (FIGS. 30 and 31). A second orhorizontal portion 1037 of the track 1035 extends substantiallyperpendicular to the longitudinal axis of the pen upper body 1003 (FIGS.30 and 31) from an end of the first portion 1036 of the track 1035. Aramp 1038 is formed at the transition from the second portion 1037 tothe first portion 1036 of the track 1035 to maintain the boss 1023 inthe second portion 1037 of the track 1035 when the dose set knob 1002 isin a non-zero position, as shown in FIGS. 26 and 27.

The insert 1031 includes at least one arm 1039 extending from acylindrical portion of the insert 1031 towards the dose set knob 1002,as shown in FIGS. 24-31. A distal end 1032 of the arm 1039 slopesdownwardly toward the distal end of the pen 1001 (FIGS. 30 and 31). Thearm 1039 of the insert 1031 engages a lug 1011 provided adjacent adistal end 1012 of the dose set knob 1002. During setting of a dose, asthe dose set knob 1002 is rotated, the lug 1011 on the dose set knob1002 engages a portion of the arm 1039 to cause the insert 1031 torotate, as shown in FIGS. 25 and 26. As the insert 1031 rotates, theinclined track portion 1036 of the insert 1031 performs a cammingfunction with the boss 1023 on the indicator member 1021 such that theindicator member 1021 retracts into the body 1003 as the boss 1023traverses the inclined track portion 1036. As the indicator member 1021retracts, the spring member 1041 compresses between the indicator member1021 and the flange 1006 of the brake tower 1005, which is fixed to thepen upper body 1003 and does not move axially or rotationally. When theboss 1023 reaches an end 1049 of the inclined track portion 1036, theindicator member 1021 is fully retracted in the pen body 1003 and is notvisible to the user, as shown in FIGS. 26 and 27. The indicator member1021 further rotates with rotation of the dose set knob 1002 until theboss 1023 reaches an end of the horizontal track portion 1037. As thedose set knob 1002 continues to rotate, the lug 1011 on the dose setknob 1002 moves away from engagement with the arm 1039 of the insert1031. Eventually the lug 1011 on the dose set knob 1002 moves far enoughthat it no longer engages the arm 1039 of the insert 1031, as shown inFIG. 26. At this point the insert 1031 no longer rotates and the doseset knob 1002 rotates and screws or advances out of the pen upper body1003 a distance corresponding to a set dose, as shown in FIG. 8. Theboss 1023 is positioned at an end 1034 of the horizontal portion 1037 ofthe track 1035, as shown in FIGS. 26 and 27. The boss 1023 beingdisposed in the horizontal portion 1037 of the track 1035 preventsmovement of the indicator member 1021 in the distal direction such thatthe spring 1041 remains compressed between the indicator member 1021 andthe flange 1006 of the brake tower 1005.

During an injection, the dose set knob 1002 is screwed back down oradvanced into the pen upper body 1003 upon the user pressing on thebutton 3 (FIGS. 7 and 8). As the dose set knob 1002 nears the end ofinjection position or the ‘0’ dose position, the dose set knob 1002 canreach a position where the lug 1011 on the dose set knob 1002 engagesthe top of the arm 1039 of the insert 1031. If the lug 1011 were to hitthe top of the arm 1039 instead of passing over the top, it is possiblethat the pen could jam and the set dose would not be allowed to becompleted. Accordingly, the arm 1039 on the insert 1031 is slopeddownwardly toward a distal end 1030 of the insert 1031. Thus, when thelug 1011 contacts the top surface of the arm 1039, the sloped proximalend of the arm 1039 facilitates the lug 1011 passing over the arm 1039so that the dose set knob 1002 can continue to its initial position or‘0’ dose position.

Once the lug 1011 passes the arm 1039, a thread 1043 on the dose setknob 2 contacts a side edge of the arm 1039, thus causing rotation ofthe insert 1031, as shown in FIG. 29. This interaction preferably occursjust before the dose set knob 1002 reaches the ‘0’ dose position. As theinsert 1031 rotates, the boss 1023 moves in the horizontal track portion1037 on the insert 1031. Once the insert 1031 rotates such that the boss1023 is positioned at the ramp 1038 in the track 1035 and the arm 1039is positioned at the second end 1063 of the recess 1061 in the dose setknob 1002. Continued rotation of the dose set knob 1002 forces the boss1023 to pass over the ramp 1038 of the track 1035 in the insert 1031.When the boss 1023 passes the ramp 1038, the spring 1041 is released.The spring 1041 drives the indicator member 1021 in a distal directionaway from the insert 1031, until the boss 1023 is positioned at an end1048 of the inclined track portion 1036 of the track 1035, as shown inFIGS. 24 and 25. The end 1048 of the track 1035 contacting the boss 1023results in a click or snap sound at the end of travel, thereby providingan audible indication that the injection is complete. The critical pointwhen the boss 1023 is positioned in the inclined track portion 1036 ofthe track 1035 is when the dose set knob 1002 has returned to the ‘0’dose position, such that the injection is completed. The axial movementof the indicator member 1021 as the boss moves in the inclined trackportion 1036 moves the portion of the indicator member 1021 into thevisible position external of the pen upper body 1003, as shown in FIG.31, thereby providing the user with a visible indication that theinjection is complete.

The injection pens described herein may utilize conventional dosesetting and injection mechanisms as disclosed, for example, in U.S. Pat.Nos. 5,626,566, 6,235,004, and 7,241,278, all of which are herebyincorporated by reference in their entirety.

While the present invention has been shown and described with referenceto particular illustrative embodiments, it is not to be restricted bysuch exemplary embodiments. It is to be appreciated that those skilledin the art can change or modify the exemplary embodiments withoutdeparting from and the scope and spirit of the present invention asdefined in the appended claims and their equivalents.

1. A medication injection pen, comprising: a housing; a dose set memberconnected to the housing for setting a dose; and a window disposed inthe housing such that the dose set member is visible in the window toindicate a zero position of the dose set member and no portion of thedose set member is visible in the window to indicate a non-zeroposition, the dose set member being in the zero position when a set dosehas been completely administered.
 2. The medication injection penaccording to claim 1, wherein the window includes a surface that issubstantially parallel to a longitudinal axis of an upper body of thepen.
 3. The medication injection pen according to claim 1, wherein thewindow includes a surface that is substantially perpendicular to alongitudinal axis of an upper body of the pen.
 4. The medicationinjection pen according to claim 1, wherein the dose set member has acut-out portion formed by an inverted substantially V-shaped cut at adistal end thereof to facilitate visibility of the outer surface of thedose set member through the window.
 5. The medication injection penaccording to claim 1, wherein an outer surface of the dose set memberhas a printed line or block that is only visible when the dose setmember is in the zero position.
 6. The medication injection penaccording to claim 1, wherein the window includes a plurality ofwindows.
 7. A medication injection pen, comprising: a housing; a doseset member connected to the housing for setting a dose; a plurality ofnumerals corresponding to a set dose; an indicator member positioneddistally of the plurality of numerals and movable between a visibleposition indicating a zero position of the dose set member and anon-visible position indicating a non-zero position of the dose setmember, the dose set member being in the zero position when a set dosehas been completely administered; wherein the indicator member isvisible in the visible position and not visible in the non-visibleposition.
 8. The medication injection pen according to claim 7, whereinthe housing is transparent or translucent to facilitate visibility ofthe indicator member.
 9. The medication injection pen according to claim7, wherein the indicator member does not rotate and is limited to axialmovement.
 10. The medication injection pen according to claim 7,wherein: an insert is fixed to the housing and has a boss extendingoutwardly therefrom, the insert includes at least one arm extendingtowards the dose set member; and a track in the indicator memberreceives the boss to guide the indicator member between the visibleposition and the non-visible position.
 11. The medication injection penaccording to claim 10, further comprising: a lug disposed adjacent to adistal end of the dose set member; wherein the arm of the insert engagesthe lug.
 12. The medication injection pen according to claim 11, whereinas the dose set member is rotated during dose setting, the lug on thedose set member engages a portion of the arm to cause the insert torotate.
 13. The medication injection pen according to claim 10, whereinthe insert includes a track; and the indicator member includes a boss;wherein as the insert rotates, the track performs a camming functionwith the boss such that the indicator member retracts as the bosstraverses the track.